Labcorp Announces 2025 Third Quarter Results

Go back to Labcorp Announces 2025 Third Quarter Results

Leerink on Laboratory Corporation of America (LH): 'Sell-off Unwarranted'

October 28, 2025 1:09 PM EDT

Leerink Partners analyst Michael Cherny reiterated an Outperform rating and $342.00 price target on Laboratory Corporation of America (NYSE: LH).

The analyst comments "We remain positive on LH and view the pronounced weakness post-Q as an opportunity for a durable compounder at a more appealing valuation. As we... More

Labcorp (LH) Tops Q3 EPS by 5c, Offers FY25 EPS Guidance

October 28, 2025 6:51 AM EDT

Labcorp (NYSE: LH) reported Q3 EPS of $4.18, $0.05 better than the analyst estimate of $4.13. Revenue for the quarter came in at $3.56 billion versus the consensus estimate of $3.56 billion.

GUIDANCE:

Labcorp sees FY2025 EPS of $16.15-$16.50, versus the consensus of $16.30.

For earnings history and earnings-related data on Labcorp (LH) click here.

... More